Trump Taps Vaccine Skeptic RFK Jr. to Lead HHS. Moderna and Novavax Stocks Slide.
Donald Trump nominated Robert F. Kennedy Jr., a vaccine skeptic and harsh critic of federal health agencies, to be his Secretary of Health and Human Services. Trump announced the nomination in a post on Truth Social.
Vaccine Makers See Stocks Fall After RFK Jr. Announcement
Pfizer's stock dropped 4.3 percent while Moderna's fell 3.1 percent and Novavax saw a 2.8 percent dip in its stock Friday morning.
Trump wants RFK Jr. to lead the federal health department
Public health experts and many Democrats characterized the decision as alarming and unprecedented. But some are eager for the vaccine skeptic to take control.
Vaccine maker stocks fall after conspiracy theory-spreading RFK Jr. tapped to lead health department
Pharmaceutical stocks continued to fall Friday after President-elect Donald Trump’s controversial nomination of vaccine skeptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services.
Doctors worried RFK Jr. will tout vaccine-skeptic views after he is picked for HHS secretary
Doctors are worried Robert F. Kennedy Jr. will tout anti-vaccine views after he was picked to lead the Department of Health and Human Services by Trump.
RFK. Jr's controversial health stances, from vaccines to raw milk
Donald Trump wants Robert F. Kennedy Jr. to be his health and human services secretary. But Kennedy has spread misinformation about vaccines, fluoride, raw milk and other health topics. Here's what he has said.
Public Health Experts Groan as RFK Jr. Pitches Vaccines as 'Personal Choice'
Vaccines are most effective at scale when enough people get them to provide "herd immunity" from a virus, doctors and officials say.
Moderna posts surprise profit as Covid vaccine sales impress, cost cuts take hold
Moderna said its newest Covid vaccine saw benefits after winning approval in the U.S. three weeks earlier than the last ...
FiercePharma12d
Moderna disappoints in RSV debut, squares up with Pfizer in COVID-19 vaccine sales
Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the ...
Medscape9h
No Benefit Seen in Holding RA/SpA Meds for COVID-19 Vaccine
Most patients with rheumatoid arthritis or spondyloarthritis had significant antibody responses to COVID vaccine boosters, whether or not their immunomodulatory medications were held.
BioSpace12d
Moderna Gets Better-Than-Expected Q3 COVID-19 Vaccine Sales, but RSV Shot Disappoints
While Moderna’s Spikevax beat Wall Street estimates in the third quarter, William Blair analyst Myles Minter in a Thursday ...
Benzinga.com11d
Moderna's Q3 Earnings Beat Overshadowed By Vaccine Demand Slowdown And Market Share Concerns, Analysts Warn
BofA Securities cuts Moderna's price target from $110 to $90 due to vaccine sales concerns. Moderna faces tough ...
Reuters12d
Moderna reports surprise profit on higher-than-expected COVID vaccine sales
Shares up nearly 5% to $54.22 in early trading Spikevax COVID vaccine sales reached $1.8 billion, beating expectations Moderna expects lower COVID vaccine sales this year compared to 2023 ...
Invezz12d
Moderna posts surprise profit as COVID vaccine sales exceed expectations
Moderna posted a profit of $13 million, or 3 cents per share. Sales of its Spikevax COVID vaccine reached $1.8 billion, ...
Moderna Stock Gains on Better-Than-Expected Covid-19 Vaccine Sales
Moderna shares jumped after the biotechnology company reported higher-than-expected sales of its Covid-19 vaccine and backed ...
Moderna swings to profits as new COVID shot powers Q3 beat
Moderna (MRNA) stock gains as company posts better than expected Q3 results driven by its updated COVID-19 vaccine. Read more ...
GEN2d
StockWatch: Vaccine, ETF Shares Drop as Trump Chooses RFK Jr. for HHS
Shares of several COVID-19 vaccine developers sank fast enough to reflect investor jitters about vaccine policy given RFK’s ...
Mena FN19h
This Is The One Reason Moderna, Novavax, And Drug Stocks Slumped
The news sent Moderna (MRNA) down by 5.62% to close at $39.77 ... Pfizer (PFE), a partner in the COVID vaccine ...